{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:24:11Z","timestamp":1761845051920,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.transproceed.2019.04.046","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T17:19:41Z","timestamp":1565111981000},"page":"2009-2013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of Cytokines, Biochemical Markers of Malnutrition and Frailty Syndrome Patients Considered for Lung Transplantation"],"prefix":"10.1016","volume":"51","author":[{"given":"Anita","family":"Stanjek-Cichoracka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wo\u017aniak-Grygiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"\u0141aszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Zembala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ochman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.04.046_bib1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1164\/rccm.201506-1150OC","article-title":"Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation","volume":"192","author":"Singer","year":"2015","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.transproceed.2019.04.046_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.12659\/AOT.904994","article-title":"Serum levels of visfatin, omentin and irisin in patients with end-stage lung disease before and after lung transplantation","volume":"22","author":"Ochman","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2019.04.046_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-008-0952-7","article-title":"Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly","volume":"27","author":"Juby","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.transproceed.2019.04.046_bib4","first-page":"217","article-title":"Diagnosis of the frailty syndrome","volume":"3","author":"Lubi\u0144ska","year":"2013","journal-title":"J\u00a0Health Sci"},{"key":"10.1016\/j.transproceed.2019.04.046_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5603\/FC.2017.0106","article-title":"[Frailty syndrome increases frequency of complications in patients undergoing invasive cardiology procedures and open-heart surgeries]","volume":"12","author":"Sobczy\u0144ska","year":"2017","journal-title":"Folia Cardiol"},{"key":"10.1016\/j.transproceed.2019.04.046_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A\u00a0global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.transproceed.2019.04.046_bib7","first-page":"194","article-title":"[Frailty\u2014a new prognostic factor in elderly patients with non-ST segment elevation myocardial infarction]","volume":"6","author":"Barylski","year":"2012","journal-title":"Geriatria"},{"key":"10.1016\/j.transproceed.2019.04.046_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/21551197.2011.623931","article-title":"The frailty syndrome: a comprehensive review","volume":"30","author":"Heuberger","year":"2011","journal-title":"J Nutr Gerontol Geriatr"},{"key":"10.1016\/j.transproceed.2019.04.046_bib9","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1073\/pnas.081072698","article-title":"Allostatic load as a marker for cumulative biological risk: MacArthur studies of successful aging","volume":"98","author":"Seeman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transproceed.2019.04.046_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3410\/B5-3","article-title":"Cytokines in chronic respiratory diseases","volume":"5","author":"Atamas","year":"2013","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.transproceed.2019.04.046_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.rmed.2005.06.016","article-title":"Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis","volume":"100","author":"Tsoutsoua","year":"2006","journal-title":"Resp Med"},{"year":"2000","series-title":"Immunology","author":"Roitt","key":"10.1016\/j.transproceed.2019.04.046_bib12"},{"key":"10.1016\/j.transproceed.2019.04.046_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/01902149109063278","article-title":"Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung","volume":"17","author":"Kunkel","year":"1991","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.transproceed.2019.04.046_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMra003200","article-title":"Idiopathic pulmonary fibrosis","volume":"345","author":"Gross","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.046_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.046_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences ininterleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.transproceed.2019.04.046_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/ajrccm.163.2.2003122","article-title":"Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease","volume":"163","author":"Aaron","year":"2001","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.transproceed.2019.04.046_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.201108-1545OC","article-title":"IL-18 induces emphysema and airway and vascular remodeling via IFN-gamma, IL-17A, and IL-13","volume":"185","author":"Kang","year":"2012","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.transproceed.2019.04.046_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cyto.2011.07.010","article-title":"Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease","volume":"56","author":"Moermans","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.transproceed.2019.04.046_bib20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.rmed.2003.07.008","article-title":"High levels ofinterleukin-6 in the exhaled breath condensate of patients with COPD","volume":"97","author":"Bucchioni","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.transproceed.2019.04.046_bib21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10875-009-9286-8","article-title":"Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD","volume":"29","author":"Sapey","year":"2009","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.transproceed.2019.04.046_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.126.3.676","article-title":"Role of interleukin-8 in the pathogenesis and treatment of COPD","volume":"126","author":"Di Stefano","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2019.04.046_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.123.4.1240","article-title":"Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4","volume":"123","author":"Beeh","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2019.04.046_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.00019207","article-title":"Interleukin-18 production and pulmonary function in COPD","volume":"31","author":"Imaoka","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.transproceed.2019.04.046_bib25","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.4049\/jimmunol.1000006","article-title":"Cytotoxic potential of lung CD8(+)T cells increases with chronic obstructive pulmonary disease severity and with in\u00a0vitro stimulation by IL-18 or IL-15","volume":"184","author":"Freeman","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2019.04.046_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","article-title":"IL-32, novel proinflammatory cytokine in chronic obstructive pulmonary disease","volume":"178","author":"Calabrese","year":"2008","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.transproceed.2019.04.046_bib27","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1378\/chest.10-0779","article-title":"Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD","volume":"139","author":"Eustace","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2019.04.046_bib28","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1378\/chest.09-3058","article-title":"Expression of the T helper 17-associatedcytokines IL-17A and IL-17F in asthma and COPD","volume":"138","author":"Doe","year":"2010","journal-title":"Chest"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519305056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519305056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:34:15Z","timestamp":1758576855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519305056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0041134519305056"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.046","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Cytokines, Biochemical Markers of Malnutrition and Frailty Syndrome Patients Considered for Lung Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}